Drawing for MCL NAVIGATOR

USPTO serial 99911569

MCL NAVIGATOR

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LIU, PHILIP
Law office
TMEG LAW OFFICE 109

What this means

Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.

Status 680: Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose.

Need help with MCL NAVIGATOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kristen S. Ruisi

Kristen S. Ruisi VENABLE, LLP151 West 42nd Street, 49th Fl.New York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable mobile application for providing medical information related to healthcare namely, cancer, autoimmune and inflammatory disease, rheumatoid arthritis, cardiovascular diseases and infectious diseases; downloadable computer software for providing medical information related to healthcare namely, cancer, autoimmune and inflammatory disease, rheumatoid arthritis, cardiovascular diseases and infectious diseases; downloadable software for enabling patients to request, receive, and manage prescriptions and orders of the pharmaceuticals and over the counter medicated preparations.ACTIVE—
035Retail pharmacy services; mail order pharmacy services; online retail pharmacy services; pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies.ACTIVE—
041Educational services, namely, providing a website featuring blogs and non-downloadable publications in the nature of informational articles and guides in the fields of cancer, autoimmune and inflammatory disease, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Educational services, namely, providing on-line newsletters in the fields of cancer, autoimmune and inflammatory disease, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Providing online non-downloadable videos in the fields of cancer, autoimmune and inflammatory disease, rheumatoid arthritis, cardiovascular diseases and infectious diseases.ACTIVE—
042Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; scientific research in the nature of conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control of goods and services for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, information tracking; packaging design.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 10, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 10, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 10, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Nov 10, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 10, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 2, 2026DOCKASSIGNED TO EXAMINER—
Oct 26, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 29, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 29, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance